Cibus’ (CBUS) Buy Rating Reiterated at Canaccord Genuity Group

Cibus (NASDAQ:CBUS)‘s stock had its “buy” rating restated by equities researchers at Canaccord Genuity Group in a report issued on Monday,Benzinga reports. They currently have a $15.00 price objective on the stock.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $20.00.

Cibus Trading Down 5.2%

CBUS stock traded down $0.09 during trading on Monday, reaching $1.56. The stock had a trading volume of 40,235 shares, compared to its average volume of 296,327. The firm has a market cap of $84.41 million, a PE ratio of -0.48 and a beta of 1.62. The stock’s 50 day moving average is $1.43 and its two-hundred day moving average is $1.55. Cibus has a 52 week low of $1.09 and a 52 week high of $4.94.

Cibus (NASDAQ:CBUS) last released its earnings results on Thursday, November 13th. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.03). The company had revenue of $0.62 million for the quarter, compared to analysts’ expectations of $1.39 million. Cibus had a negative net margin of 3,133.92% and a negative return on equity of 133.90%. On average, research analysts anticipate that Cibus will post -2.96 EPS for the current year.

Institutional Investors Weigh In On Cibus

Several institutional investors have recently made changes to their positions in the company. Blair William & Co. IL bought a new stake in Cibus in the first quarter worth about $28,000. Rockland Trust Co. purchased a new stake in shares of Cibus in the 3rd quarter worth $26,000. Qube Research & Technologies Ltd bought a new position in shares of Cibus during the 2nd quarter worth $39,000. Warberg Asset Management LLC purchased a new position in shares of Cibus during the second quarter valued at $41,000. Finally, Bank of America Corp DE raised its holdings in shares of Cibus by 113.4% in the fourth quarter. Bank of America Corp DE now owns 35,536 shares of the company’s stock valued at $99,000 after acquiring an additional 18,885 shares in the last quarter. Institutional investors own 33.81% of the company’s stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.